Mice, men and MHC supertypes

Claus Lundegaard

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    Mice are still the most used model organism in initial phases of vaccine design. Bioinformatics is becoming increasingly more important in vaccine development, both for the design of novel simplified epitope-based vaccines and also in order to understand the specific immune response of selected vaccine formulations. Toxoplasma gondii, an intracellular parasite, causes severe neurologic and ocular disease in congenitally infected and immunocompromised individuals. No protective vaccine exists against human toxoplasmosis. However, studies with mice have revealed immunodominant cytotoxic T lymphocyte epitopes originating from type II strains. These verified epitopes might be useful in human vaccines as the peptide binding repertoire of H-2L(d) MHC and MHCs belonging to the HLA-B07 supertype are very similar. Here, the results obtained using these epitopes in BALB/c as well as transgenic HLA-B*0702 mice are discussed. The stunning results obtained from the use of refined computational methods for the prediction of cytotoxic T lymphocyte epitopes are also discussed. The results highlight some important issues regarding both the use of mice but also the choice of bioinformatics methods in vaccine development.
    Original languageEnglish
    JournalExpert Review of Vaccines
    Volume9
    Issue number7
    Pages (from-to)713-718
    ISSN1476-0584
    DOIs
    Publication statusPublished - 2010

    Cite this

    Lundegaard, Claus. / Mice, men and MHC supertypes. In: Expert Review of Vaccines. 2010 ; Vol. 9, No. 7. pp. 713-718.
    @article{83445c08e3e84fa58f605b1b2b27a8c8,
    title = "Mice, men and MHC supertypes",
    abstract = "Mice are still the most used model organism in initial phases of vaccine design. Bioinformatics is becoming increasingly more important in vaccine development, both for the design of novel simplified epitope-based vaccines and also in order to understand the specific immune response of selected vaccine formulations. Toxoplasma gondii, an intracellular parasite, causes severe neurologic and ocular disease in congenitally infected and immunocompromised individuals. No protective vaccine exists against human toxoplasmosis. However, studies with mice have revealed immunodominant cytotoxic T lymphocyte epitopes originating from type II strains. These verified epitopes might be useful in human vaccines as the peptide binding repertoire of H-2L(d) MHC and MHCs belonging to the HLA-B07 supertype are very similar. Here, the results obtained using these epitopes in BALB/c as well as transgenic HLA-B*0702 mice are discussed. The stunning results obtained from the use of refined computational methods for the prediction of cytotoxic T lymphocyte epitopes are also discussed. The results highlight some important issues regarding both the use of mice but also the choice of bioinformatics methods in vaccine development.",
    author = "Claus Lundegaard",
    year = "2010",
    doi = "10.1586/ERV.10.76",
    language = "English",
    volume = "9",
    pages = "713--718",
    journal = "Expert Review of Vaccines",
    issn = "1476-0584",
    publisher = "CRC Press/Balkema",
    number = "7",

    }

    Mice, men and MHC supertypes. / Lundegaard, Claus.

    In: Expert Review of Vaccines, Vol. 9, No. 7, 2010, p. 713-718.

    Research output: Contribution to journalJournal articleResearchpeer-review

    TY - JOUR

    T1 - Mice, men and MHC supertypes

    AU - Lundegaard, Claus

    PY - 2010

    Y1 - 2010

    N2 - Mice are still the most used model organism in initial phases of vaccine design. Bioinformatics is becoming increasingly more important in vaccine development, both for the design of novel simplified epitope-based vaccines and also in order to understand the specific immune response of selected vaccine formulations. Toxoplasma gondii, an intracellular parasite, causes severe neurologic and ocular disease in congenitally infected and immunocompromised individuals. No protective vaccine exists against human toxoplasmosis. However, studies with mice have revealed immunodominant cytotoxic T lymphocyte epitopes originating from type II strains. These verified epitopes might be useful in human vaccines as the peptide binding repertoire of H-2L(d) MHC and MHCs belonging to the HLA-B07 supertype are very similar. Here, the results obtained using these epitopes in BALB/c as well as transgenic HLA-B*0702 mice are discussed. The stunning results obtained from the use of refined computational methods for the prediction of cytotoxic T lymphocyte epitopes are also discussed. The results highlight some important issues regarding both the use of mice but also the choice of bioinformatics methods in vaccine development.

    AB - Mice are still the most used model organism in initial phases of vaccine design. Bioinformatics is becoming increasingly more important in vaccine development, both for the design of novel simplified epitope-based vaccines and also in order to understand the specific immune response of selected vaccine formulations. Toxoplasma gondii, an intracellular parasite, causes severe neurologic and ocular disease in congenitally infected and immunocompromised individuals. No protective vaccine exists against human toxoplasmosis. However, studies with mice have revealed immunodominant cytotoxic T lymphocyte epitopes originating from type II strains. These verified epitopes might be useful in human vaccines as the peptide binding repertoire of H-2L(d) MHC and MHCs belonging to the HLA-B07 supertype are very similar. Here, the results obtained using these epitopes in BALB/c as well as transgenic HLA-B*0702 mice are discussed. The stunning results obtained from the use of refined computational methods for the prediction of cytotoxic T lymphocyte epitopes are also discussed. The results highlight some important issues regarding both the use of mice but also the choice of bioinformatics methods in vaccine development.

    U2 - 10.1586/ERV.10.76

    DO - 10.1586/ERV.10.76

    M3 - Journal article

    VL - 9

    SP - 713

    EP - 718

    JO - Expert Review of Vaccines

    JF - Expert Review of Vaccines

    SN - 1476-0584

    IS - 7

    ER -